Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bangor, ME
NPI
1700804671
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
905 Union St, Suite 11
Bangor, ME, 04401
Phone (207) 973-7334
Medicare paid, 2024
$20K
432 services
Medicare patients, 2024
189
Average age 72
Drug cost, 2024
$1.1M
3,181 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Katarzyna Sadurska was code 99214 (office e&m - established), 161 times for 123 patients. In total Katarzyna Sadurska billed 432 services in 9 codes, and Medicare paid $20K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 161 | 123 | $63.25 | $10K |
| 99213 Office E&M - Established | Office | 128 | 96 | $45.64 | $5,842 |
| 95251 Test - Miscellaneous | Office | 126 | 78 | $24.10 | $3,037 |
By year: 2022 $22K for 428 services; 2023 $23K for 465 services; 2024 $20K for 432 services.
Medicare prescription drug claims, 2024
In 2024, the drug Katarzyna Sadurska prescribed most often to Medicare patients was Novolog Flexpen (Insulin Aspart), with 226 prescriptions and refills. In total Katarzyna Sadurska wrote 3,181 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Novolog Flexpen Insulin Aspart | 226 | 522 | 75 | $56K |
| Levothyroxine Sodium Generic | 200 | 539 | 57 | $1,716 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 179 | 430 | 62 | $28K |
| Ultra-Fine Micro Pen Needle Pen Needle, Diabetic | 169 | 372 | 52 | $25K |
| Trulicity Dulaglutide | 156 | 179 | 22 | $171K |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 140 | 355 | 48 | $79K |
| Jardiance Empagliflozin | 112 | 256 | 33 | $142K |
| Humalog Kwikpen U-100 Insulin Lispro | 108 | 280 | 43 | $35K |
| Ultra-Fine Short Pen Needle Pen Needle, Diabetic | 105 | 261 | 32 | $18K |
| Farxiga Dapagliflozin Propanediol | 97 | 181 | 20 | $99K |
| Metformin Hcl Er Metformin Hcl | 82 | 232 | 27 | $829 |
| Metformin Hcl Generic | 80 | 240 | 27 | $410 |
| Novolog Insulin Aspart | 79 | 194 | 25 | $28K |
| Humalog Insulin Lispro | 78 | 144 | 21 | $16K |
| Methimazole Generic | 74 | 189 | 20 | $748 |
Brand drugs: 2,037 claims; generic drugs: 622 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Katarzyna Sadurska were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.